Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Pediatr Dermatol ; 40(6): 1081-1085, 2023.
Article in English | MEDLINE | ID: mdl-37872643

ABSTRACT

Oculocutaneous albinism (OCA) is a genetic disease caused by disorders in melanin synthesis or distribution. In this descriptive study conducted in a tertiary care pediatric hospital, patients with a clinical diagnosis of OCA and genetic study were retrospectively recruited and underwent dermatological and ophthalmological exam, including optical coherence tomography (OCT) and digital dermoscopy. Our findings revealed milder OCA phenotypic expression in individuals harboring single pathogenic mutations in conjunction with polymorphisms, as well as in those with mutations of uncertain significance. Regardless OCA subgroup, severe phenotypes of OCA were associated with a higher number of mutations/polymorphisms in melanin biosynthesis genes and paler dermoscopic patterns, such as vascular pattern, which was the most common pattern in our series.


Subject(s)
Albinism, Oculocutaneous , Melanins , Humans , Child , Melanins/genetics , Retrospective Studies , Mutation , Phenotype , Albinism, Oculocutaneous/genetics , Albinism, Oculocutaneous/diagnosis , Albinism, Oculocutaneous/pathology
3.
BMJ Case Rep ; 15(5)2022 May 18.
Article in English | MEDLINE | ID: mdl-35584860

ABSTRACT

Calcinosis cutis (CC) is the umbrella term for calcium salt deposition on skin and subcutaneous tissue. We present a unique case of CC associated with anti-Mi2-positive dermatomyositis, having a distinctive distribution of subcutaneous calcifications appearing as a 'lumbar belt'. Treatment of CC remains challenging for clinicians due to a lack of high-quality evidence. Corticosteroids, methotrexate, bisphosphonates, intravenous immunoglobulin replacement, rituximab and sodium thiosulfate failed to halt calcinosis progression in this case. Newer therapies, such as Janus kinase inhibitors, should be considered.


Subject(s)
Calcinosis , Dermatomyositis , Skin Diseases , Calcinosis/diagnostic imaging , Calcinosis/drug therapy , Dermatomyositis/diagnosis , Dermatomyositis/drug therapy , Humans , Immunoglobulins, Intravenous/therapeutic use , Rituximab
SELECTION OF CITATIONS
SEARCH DETAIL
...